Zhican Qu

418 total citations
18 papers, 341 citations indexed

About

Zhican Qu is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Zhican Qu has authored 18 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Genetics. Recurrent topics in Zhican Qu's work include Angiogenesis and VEGF in Cancer (5 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Melanoma and MAPK Pathways (3 papers). Zhican Qu is often cited by papers focused on Angiogenesis and VEGF in Cancer (5 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Melanoma and MAPK Pathways (3 papers). Zhican Qu collaborates with scholars based in United States, China and Canada. Zhican Qu's co-authors include Ali Zamani, Wenyan Lü, Yonghe Li, Heather N. Tinsley, Adam B. Keeton, Gary A. Piazza, Florian Kern, Jaideep V. Thottassery, Louise Westbrook and Rongbao Li and has published in prestigious journals such as Cancer Research, Oncogene and FEBS Letters.

In The Last Decade

Zhican Qu

17 papers receiving 336 citations

Peers

Zhican Qu
BaoHan T. Vo United States
Yuan Chang-ji China
Ana C. Millena United States
Bo‐Syong Pan United States
Bin Yuan China
Miao He China
Kristofer C. Berrett United States
Huinan Qu China
Yongkang Zou China
BaoHan T. Vo United States
Zhican Qu
Citations per year, relative to Zhican Qu Zhican Qu (= 1×) peers BaoHan T. Vo

Countries citing papers authored by Zhican Qu

Since Specialization
Citations

This map shows the geographic impact of Zhican Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhican Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhican Qu more than expected).

Fields of papers citing papers by Zhican Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhican Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhican Qu. The network helps show where Zhican Qu may publish in the future.

Co-authorship network of co-authors of Zhican Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhican Qu. A scholar is included among the top collaborators of Zhican Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhican Qu. Zhican Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hu, Xuan, Ziyan Shen, Ke Ma, et al.. (2025). NIR II light-driven nanomotor synergistically enhances immunogenic cell death through photothermal and chemodynamic therapy for melanoma immunotherapy. Journal of Colloid and Interface Science. 694. 137688–137688. 14 indexed citations
2.
Zamani, Ali & Zhican Qu. (2012). Serotonin activates angiogenic phosphorylation signaling in human endothelial cells. FEBS Letters. 586(16). 2360–2365. 66 indexed citations
3.
Karmali, Rashida A., Yulia Maxuitenko, Greg Gorman, & Zhican Qu. (2012). Combinatorial treatment with carboxyamidotriazole- orotate and temozolomide in sc-implanted human LOX IMVI melanoma xenografts. 2(5). 4 indexed citations
4.
Zhai, Ling, Ali Zamani, Ximeng Liu, et al.. (2012). Abstract 3727: Targeting autotaxin to reduce chemotherapy resistance in ovarian cancer. Cancer Research. 72(8_Supplement). 3727–3727. 2 indexed citations
5.
Zamani, Ali, Anshu M. Roy, Ling Zhai, et al.. (2012). Abstract 2333: Serotonin: A known neurotransmitter functions as an angiokine to support cancer progression. Cancer Research. 72(8_Supplement). 2333–2333. 1 indexed citations
6.
Lin, Cuihong, Wenyan Lü, Ling Zhai, et al.. (2011). Mesd is a general inhibitor of different Wnt ligands in Wnt/LRP signaling and inhibits PC-3 tumor growth in vivo. FEBS Letters. 585(19). 3120–3125. 29 indexed citations
7.
Zamani, Ali, Ling Zhai, Anshu M. Roy, et al.. (2011). Abstract 5154: Serotonin signaling as a novel target of tumor angiogenesis. Cancer Research. 71(8_Supplement). 5154–5154. 3 indexed citations
8.
Roy, Anshu M., Ali Zamani, Subramaniam Ananthan, & Zhican Qu. (2009). Abstract #4035: Serotonin: A neurotransmitter as well as a potent angiokine. Cancer Research. 69. 4035–4035. 1 indexed citations
9.
Lü, Wenyan, Heather N. Tinsley, Adam B. Keeton, et al.. (2008). Suppression of Wnt/β-catenin signaling inhibits prostate cancer cell proliferation. European Journal of Pharmacology. 602(1). 8–14. 94 indexed citations
10.
Qu, Zhican, Anshu M. Roy, Louise Westbrook, et al.. (2008). Vascular Endothelial Growth Factor Reduces Tamoxifen Efficacy and Promotes Metastatic Colonization and Desmoplasia in Breast Tumors. Cancer Research. 68(15). 6232–6240. 33 indexed citations
11.
Wang, Yimin, et al.. (2007). Activation loop phosphorylation‐independent kinase activity of human protein kinase C ζ. Proteins Structure Function and Bioinformatics. 67(3). 709–719. 6 indexed citations
12.
Roy, Anshu M., Rongbao Li, & Zhican Qu. (2006). Antiangiogenic activity of clofarabine. Cancer Research. 66. 55–56. 3 indexed citations
13.
14.
Roy, Anshu M., Kamal N. Tiwari, William B. Parker, et al.. (2006). Antiangiogenic activity of 4′-thio-β-d-arabinofuranosylcytosine. Molecular Cancer Therapeutics. 5(9). 2218–2224. 12 indexed citations
15.
Maxuitenko, Yulia, John J. Rinehart, William R. Waud, et al.. (2005). A preclinical study of tamoxifen in combination with bevacizumab (Avastin) for the treatment of ER-positive breast cancer. Cancer Research. 65. 254–254.
16.
Kim, Susan J., Zhican Qu, Jeffrey Milbrandt, & Min Zhuo. (2005). A Transcription Factor for Cold Sensation!. Molecular Pain. 1. 11–11. 3 indexed citations
17.
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by BaoHan T. Vo Breakdown of academic impact, for papers by Yuan Chang-ji Breakdown of academic impact, for papers by Ana C. Millena Breakdown of academic impact, for papers by Bo‐Syong Pan Breakdown of academic impact, for papers by Bin Yuan Breakdown of academic impact, for papers by Miao He Breakdown of academic impact, for papers by Kristofer C. Berrett Breakdown of academic impact, for papers by Huinan Qu Breakdown of academic impact, for papers by Yongkang Zou
Rankless by CCL
2026